van DoremalenN, BushmakerT, MorrisDH, HolbrookMG, GambleA, WilliamsonBN, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med, 2020; 382(16):1564-1567.
2.
ChinAWH, ChuJTS, PereraMRA, HuiKPY, YenHL, ChanMCW, et al. Stability of SARS-CoV-2 in different environmental conditions. Lancet Microbe, 2020; 1(1):e10.
3.
MeyerowitzEA, RichtermanA, GandhiRT, SaxPE. Transmission of SARS-CoV-2: a review of viral, host, and environmental factors. Ann Intern Med, 2021; 174(1):69-79.
4.
RanneyML, GriffethV, JhaAK. Critical supply shortages - the need for ventilators and personal protective equipment during the COVID-19 pandemic. N Engl J Med, 2020; 382(18):e41.
5.
LiJ, AlolaiwatA, FinkJB, DhandR. Aerosol-generating procedures and virus transmission. Respir Care, 2022; 67(8):1022-1042.
6.
GaeckleNT, LeeJ, ParkY, KreykesG, EvansMD, HoganCJJr.. Aerosol generation from the respiratory tract with various modes of oxygen delivery. Am J Respir Crit Care Med, 2020; 202(8):1115-1124.
7.
LiJ, FinkJB, ElshafeiAA, StewartLM, BarbianHJ, MirzaSH, et al. Placing a mask on COVID-19 patients during high-flow nasal cannula therapy reduces aerosol particle dispersion. ERJ Open Res, 2021; 7(1):00519-2020.
8.
TakazonoT, YamamotoK, OkamotoR, MorimotoS, IzumikawaK, MukaeH. Effects of surgical masks on droplet dispersion under various oxygen delivery modalities. Crit Care, 2021; 25(1):89.
9.
RocaO, PachecoA, RodonJ, AntónA, Vergara-AlertJ, ArmadansL, et al. Nasal high-flow oxygen therapy in COVID-19 patients does not cause environmental surface contamination. J Hosp Infect, 2021; 116:103-105.
10.
WinslowRL, ZhouJ, WindleEF, NurI, LallR, JiC, et al. SARS-CoV-2 environmental contamination from hospitalized patients with COVID-19 receiving aerosol-generating procedures. Thorax, 2022; 77(3):259-267.
11.
ThuressonS, FraenkelCJ, SasinovichS, SoldemyrJ, WidellA, MedstrandP, et al. Airborne severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in hospitals: effects of aerosol-generating procedures, HEPA-filtration units, patient viral load, and physical distance. Clin Infect Dis, 2022; 75(1):e89-e96.
NairPR, HarithaD, BeheraS, KayinaCA, MaitraS, AnandRK, et al. Comparison of high-flow nasal cannula and noninvasive ventilation in acute hypoxemic respiratory failure due to severe COVID-19 pneumonia. Respir Care, 2021; 66(12):1824-1830.
14.
Ospina-TascónGA, Calderón-TapiaLE, GarcíaAF, ZaramaV, Gómez-ÁlvarezF, Álvarez-SaaT, et al. HiFLo-Covid Investigators. Effect of high-flow oxygen therapy vs conventional oxygen therapy on invasive mechanical ventilation and clinical recovery in patients with severe COVID-19: a randomized clinical trial. JAMA, 2021; 326(21):2161-2171.
15.
Dell’OlioA, VocaleC, PrimaveraA, PisaniL, AltavillaS, RoncaratiG, et al. Environmental contamination by SARS-CoV-2 during noninvasive ventilation in COVID-19. Respir Care, 2023; 68(1):1-7.
16.
RamseyME, FaugnoAJ, PuryearWB, LeeBC, FossAD, LambertLH, et al. Characterization of SARS-CoV-2 aerosols produced during noninvasive respiratory support of COVID-19 patients. Respir Care, 2023; 68(1):8-17.
17.
DhandR, LiJ. Coughs and sneezes: their role in transmission of respiratory viral infections, including SARS-CoV-2. Am J Respir Crit Care Med, 2020; 202(5):651-659.
18.
RouseBT, SehrawatS. Immunity and immunopathology to viruses: what decides the outcome?. Nat Rev Immunol, 2010; 10(7):514-526.
